LivaNova balances rising EPS and stable revenue with legal liabilities and segment pressure in depression treatment. See why ...

ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion ...

Patients presented with a mean NIHSS score of 15.4 (range 0–36, ±7.0), and 71 (37.2%) patients received IV tPA. The average time from onset ... due to abortion of the procedure secondary to ...